Fortress Biotech, Inc. 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-11 4:29 pm Purchase |
2025-03-09 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
6,922,249 11.200% |
18,500 (+0.27%) |
Filing |
| 2025-01-03 6:26 pm Purchase |
2024-12-31 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
6,903,749 13.500% |
2,468,215 (+55.65%) |
Filing |
| 2024-10-01 4:15 pm Purchase |
2024-09-27 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
4,435,534 9.800% |
146,341 (+3.41%) |
Filing |
| 2024-05-17 5:13 pm Purchase |
2024-05-16 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
4,289,193 11.200% |
1,492,915 (+53.39%) |
Filing |
| 2024-03-22 6:24 pm Purchase |
2024-03-20 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,796,278 7.500% |
352,039 (+14.40%) |
Filing |
| 2023-09-26 4:16 pm Purchase |
2023-09-25 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,444,239 11.300% |
80,906 (+3.42%) |
Filing |
| 2023-07-06 4:44 pm Purchase |
2023-06-30 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,363,333 13.600% |
81,406 (+3.57%) |
Filing |
| 2023-04-19 4:24 pm Purchase |
2023-03-31 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,281,927 17.500% |
78,214 (+3.55%) |
Filing |
| 2023-01-13 4:13 pm Purchase |
2023-01-05 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,203,713 19.300% |
2,203,713 (New Position) |
Filing |